State Board of Administration of Florida Retirement System’s Cartesian Therapeutics RNAC Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio RNAC Stock Details RNAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,017	Closed	-$21K	–	2408
2023 Q4	$21K	Buy	+1,017	New	+$30.4K	﹤0.01%	2402
2022 Q2	–	Sell	-850	Closed	-$31K	–	2394
2022 Q1	$31K	Hold	850	–	–	﹤0.01%	2361
2021 Q4	$83K	Buy	850 +6	+0.7%	+$645	﹤0.01%	2339
2021 Q3	$105K	Hold	844	–	–	﹤0.01%	2349
2021 Q2	$106K	Buy	844 +4	+0.5%	+$476	﹤0.01%	2356
2021 Q1	$114K	Hold	840	–	–	﹤0.01%	2297
2020 Q4	$76K	Hold	840	–	–	﹤0.01%	2305
2020 Q3	$63K	Hold	840	–	–	﹤0.01%	2264
2020 Q2	$72K	Buy	+840	New	+$76.1K	﹤0.01%	2260

Other funds holding RNAC

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Board of Administration of Florida Retirement System's RNAC Position: Q1 2024 in Review

State Board of Administration of Florida Retirement System sold out of Cartesian Therapeutics (RNAC) in Q1 2024, closing a stake of 1,017 shares — an estimated $21K sold.

State Board of Administration of Florida Retirement System first reported a position in RNAC in Q2 2020 and held it in 9 quarters. The position peaked at $114K in Q1 2021. 69 funds tracked by Wall St. Rank hold RNAC as of Q1 2024.

State Board of Administration of Florida Retirement System reported no remaining Cartesian Therapeutics position as of Q1 2024 after selling out during the quarter.
State Board of Administration of Florida Retirement System sold 1,017 Cartesian Therapeutics shares in Q1 2024, an estimated $21K.
State Board of Administration of Florida Retirement System first reported a position in Cartesian Therapeutics in Q2 2020 and held it in 9 quarters.
State Board of Administration of Florida Retirement System's Cartesian Therapeutics position peaked at $114K in Q1 2021.
69 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q1 2024.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q1 2024, filed 8 May 2024.